can-2409,nivolumab
candel therapeutics,bms
['can-2409']
late breaking presentation by dr patrick wen at #sitc22: induction of systemic immune response after single administration of can-2409 in high-grade glioma. #candeltherapeutics 
Physician-scientist. Immunologist. CEO of Candel Therapeutics ($CADL), focused on development of new immunotherapies for cancer. Views expressed here are my own